This study is designed to utilize epidemiological and laboratory methods to delineate the nature of the association between immunodeficiency and cancer. When successfully executed, our research will demonstrate to what extent the Wiskott-Aldrich Syndrome (WAS) gene(s) is associated with increased risk of cancer in affecteds and carriers, and whether the frequency of malignancy is higher in some WAS families than in others.